China's CanSino, Sinopharm unit, seek approval for Covid vaccines

Beijing (AFP) Feb 24, 2021

China's CanSino Biologics and a unit of Sinopharm said Wednesday they have applied for public use of their Covid-19 vaccines, and announced efficacy rates. Sinopharm affiliate Wuhan Institute Of Biological Products said in a statement its vaccine's efficacy rate was 72.51 percent, while the overall efficacy for CanSino's stood at 65.28 percent after 28 days. If their applications are su